Postmenopausal Virilization Due to a Rare Left Ovarian Androgen-Secreting Leydig Cell Tumor Identified by Ovarian Vein Sampling

    November 2022 in “ Journal of the Endocrine Society
    Shirley Shuster, Sara M. Awad
    Image
    Studysummary This case report highlights the diagnostic challenge of identifying androgen-secreting ovarian Leydig cell tumors in postmenopausal women when imaging fails to reveal masses, emphasizing the usefulness of ovarian vein sampling for localization.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    A 57-year-old postmenopausal woman presented with a 10-year history of hirsutism and a 4-year history of virilization, including voice deepening, excessive hair growth, male pattern baldness, and clitoromegaly. Her total testosterone levels were significantly elevated at 11.5nmol/L, while other hormonal tests were normal. Imaging studies failed to identify any adrenal or ovarian masses. However, ovarian vein sampling indicated a strong lateralization to the left ovary, with a total testosterone level of 780nmol/L. Subsequent bilateral salpingo-oophorectomy revealed a rare left ovarian Leydig cell tumor, which was the source of the androgen secretion. Post-operatively, the patient's testosterone levels normalized, and her virilizing symptoms improved. This case underscores the importance of considering rare androgen-secreting ovarian tumors in postmenopausal virilization and the utility of ovarian vein sampling for tumor localization when imaging is inconclusive.
    Discuss this study in the Community โ†’